The use of oncofetal ferritin-bearing lymphocytes as a marker for the screening, diagnosis, and follow-up of patients with early breast malignancy screening of 3400 women.
作者:
主题词
抗原, 肿瘤(Antigens, Neoplasm);乳腺肿瘤(Breast Neoplasms);女(雌)性(Female);铁蛋白质类(Ferritins);随访研究(Follow-Up Studies);人类(Humans);普查(Mass Screening);肿瘤分期(Neoplasm Staging);预后(Prognosis);危险因素(Risk Factors);T淋巴细胞(T-Lymphocytes)
DOI
10.1002/1097-0142(19890801)64:3<691::aid-cncr2820640321>3.0.co;2-0
PMID
2787200
发布时间
2019-06-19
- 浏览26

Cancer
691-7页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文